Developer docs
API playgroundTry for free, no card

Search company profiles

Opsens

Full company profile

uuid0005ytk

Namestring
Opsens
Legal namestring
Opsens Inc.
Websiteurl
opsens.com
Company typeenum
Private
Founded yearint
2003
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersQuebec, Canada
HQ citystring
Quebec
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fiber optic sensors, medical pressure guidewires, interventional cardiology devices, industrial sensing solutions, downhole pressure monitoring
Industry1 code
1Pressure & Force Sensors (Pressure/Strain/Load Cells)
CodeHDAHALABPrimaryYes
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals334515
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Instruments For Meas & Testing Of Electricity & Elec Signals3825
Product category
Medical Devices - Interventional Cardiology Pressure Guidewires
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical product sales (FFR guidewires, SavvyWire, OptoMonitor)
TypeHardware Sales
Description

One-time hardware sales of interventional cardiology fiber optic pressure guidewires (OptoWire, OptoWire II, OptoWire III) and SavvyWire, plus associated OptoMonitor signal conditioners, sold to hospitals and cardiology centers globally.

opsens.com
2Industrial fiber optic sensor sales (Oil & Gas, Mining, Aerospace, Defense)
TypeHardware Sales
Description

One-time hardware sales of fiber optic pressure, temperature, strain and deformation sensors (OPP-W, PowerSens, RadSens, OPP-M25) and complete sensing systems for industrial customers including oil & gas producers, mining operators, aerospace integrators, and defense organizations.

opsens.com
3Distribution rights / milestone payments
TypeLicensing Royalties
Description

Recognition of deferred distribution rights and milestone payments from partners upon receipt of regulatory approvals (e.g., US$1M from Japanese partner on Shonin approval, US$2M deferred revenue on CE mark), tied to regional distribution agreements.

opsens.com
4Software / algorithm licensing (FFR and dPR)
TypeLicensing Royalties
Description

Integration licensing of OptoWire's dPR and FFR algorithms within third-party cardiovascular systems (e.g., Cathmedical Cardiovascular's Picasso System in Spain).

opsens.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Quote-based hardware pricing for FFR guidewires (per unit)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

No publicly disclosed unit prices; orders referenced include $1.2M for FFR products from Japan (November 2015) and $1M+ industrial sensor orders from mining operators.

opsens.com
2Project-based industrial system pricing (mining, oil & gas, aerospace)
ModelOtherBilling cadencePay-as-you-go
Notes

Custom-quoted multi-well and multi-system orders, e.g., 48-well OPP-W sensor orders, $1M+ copper mining optical sensor order, CO2-EOR well monitoring projects.

opsens.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Opsens Medical
Description

Medical business unit focused on interventional cardiology FFR and TAVR pressure guidewires (OptoWire, OptoMonitor, SavvyWire).

opsens.com
+1 more record
Core offering1 text field

Opsens designs, manufactures, and sells proprietary fiber optic pressure and temperature sensors for two markets: (1) interventional cardiology, where its OptoWire family of nitinol-based optical pressure guidewires, OptoMonitor display units, dPR diagnostic algorithm, and SavvyWire for TAVR procedures enable Fractional Flow Reserve (FFR) measurement and coronary artery disease diagnosis, and (2) industrial applications including Oil & Gas downhole monitoring (OPP-W sensors), power transformer thermal monitoring (PowerSens II), defense radiation sensing (RadSens), and life sciences miniature sensors (OPP-M25).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 100,000 OptoWire cases performed cumulatively by May 2020 (up from 50,000 patients in Nov 2018 and 1,000th procedure in Oct 2015)
+4 more records
Product overview1 text field

Opsens operates a platform-plus-modules architecture split between two business units: Opsens Medical and Opsens Solutions. Opsens Medical is the core interventional cardiology offering built around the OptoWire family of nitinol-based optical pressure guidewires (OptoWire I, II, III) used for Fractional Flow Reserve (FFR) and diastolic Pressure Ratio (dPR) measurement, paired with the OptoMonitor / OptoMonitor II display units. This medical portfolio was expanded with the SavvyWire, a second-generation fiber optic guidewire for Transcatheter Aortic Valve Replacement (TAVR) procedures that leverages the same proprietary miniature optical pressure sensing technology. Opsens's algorithms (dPR and FFR) are integrated into partner systems such as Cathmedical Cardiovascular's Picasso System, and its fiber optic pressure sensing technology was FDA-approved for use in Abiomed's Impella cardiac pump. Opsens Solutions is the industrial sister-unit providing fiber optic sensing solutions for Oil & Gas (OPP-W pressure and temperature sensors for SAGD wells and reservoir monitoring), power transformers (PowerSens II signal conditioner), defense (RadSens System for RADHAZ applications), and life sciences (OPP-M25 miniature pressure sensor). As of December 2023, Opsens is a wholly-owned subsidiary of Haemonetics Corporation (NYSE: HAE), and the combined medical sensor-guided technology portfolio is now marketed through Haemonetics.

Product and service8 records
1OptoWire Family (OptoWire I, II, III)
CategoryInterventional Cardiology / FFR Measurement
Description

Nitinol-based optical pressure guidewires for Fractional Flow Reserve (FFR) and diastolic Pressure Ratio (dPR) measurement in interventional cardiology. Available in three generations with progressively improved hydrophilic coating and flexibility for navigation in tortuous and calcified vessels. Immune to adverse effects from blood contact with reliable zero-drift measurements. Sold to hospitals and cardiology centers.

2OptoMonitor / OptoMonitor II
CategoryInterventional Cardiology / FFR Measurement
Description

Display and interface hardware unit that pairs with the OptoWire to record, display, and analyze FFR and dPR measurements during coronary interventions. Provides connection reliability, stable connect/re-connect capability without loss of signal stability, and integrates with FFR and dPR algorithms.

3SavvyWire
CategoryInterventional Cardiology / Structural Heart
Description

Second-generation fiber optic pressure guidewire for Transcatheter Aortic Valve Replacement (TAVR) procedures in the structural heart market. A 3-in-1 guidewire combining pressure measurement with valve delivery workflow to optimize TAVR valve positioning. Received FDA clearance September 2022 and Health Canada approval April 2022.

4dPR (diastolic Pressure Ratio) Algorithm
CategoryDiagnostic Algorithm / Cardiology Software
Description

Proprietary diagnostic algorithm for the assessment of coronary stenosis with the heart at rest. Operates with the OptoWire and OptoMonitor system to expand diagnostic capability beyond stress-based FFR. Licensed and integrated into third-party cardiovascular systems (e.g., Cathmedical Cardiovascular's Picasso System in Spain).

5OPP-W Fiber Optic Pressure and Temperature Sensors
CategoryIndustrial Oil & Gas Sensing
Description

High-end fiber optic pressure and temperature sensors for Oil & Gas producers, providing reliable real-time downhole pressure and temperature data for SAGD wells, electrical submersible pumps, CO2-EOR projects, and reservoir monitoring. Used in high-temperature and harsh downhole environments. Sold to oil sands and heavy oil producers primarily in Western Canada.

6PowerSens II Signal Conditioner
CategoryIndustrial Power Transformer Monitoring
Description

Signal conditioner for the power transformer sector, used with fiber optic temperature sensors for direct thermal monitoring of power transformers. Sold to power utilities and transformer manufacturers.

7RadSens System
CategoryDefense / Radiation Sensing
Description

Fiber optic radiation sensing system for RADHAZ (Radiation Hazards) applications. Sold to defense organizations including BAE Systems and UK Ministry of Defence.

8OPP-M25 Miniature Pressure Sensor
CategoryIndustrial / Life Sciences Sensing
Description

Miniature fiber optic pressure sensor for life sciences and medical device applications where small form factor and high accuracy are required. Used in OEM applications and laboratory instrumentation.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-12-12
Description

Haemonetics Corporation (NYSE: HAE) completed acquisition of OpSens on December 12, 2023, acquiring all outstanding shares of OpSens. OpSens' common shares were delisted from the Toronto Stock Exchange and withdrawn from the OTCQX. Opsens is now part of Haemonetics' Hospital business unit and OpSens Medical products (OptoWire, SavvyWire) are marketed via Haemonetics' Sensor-Guided Technology platform. OpSens shares now host its investor relations on Haemonetics' GCS-Web platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-03-14
Description

Interventional Specialty Diagnostics Agreement with Premier for SavvyWire (March 14, 2023); prior agreement for OptoWire III (July 11, 2022). Premier GPO contracts provide Opsens' medical devices access to Premier's network of U.S. hospitals.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2022-02-01
Description

Opsens' fiber optic sensing technology integrated into Abiomed's Impella Cardiac Pump (FDA approval announced April 2018). A 4-year supply agreement extension to 2028 was announced February 1, 2022, deepening Opsens' presence within Abiomed's interventional cardiology platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-04-07
Description

Innovative Technology Contract awarded by Vizient for OptoWire III (April 7, 2021), expanding access to Vizient's U.S. hospital member base.

Strategic tierMinorTypeOthersAnnounced on2021-02-08
Description

Opsens Solutions fiber optic sensing technology selected for the ITER project (February 8, 2021), providing fiber optic sensing for this international nuclear fusion research project.

6Major U.S. Group Purchasing Organization
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-10-14
Description

Opsens was awarded a contract by a major U.S. Group Purchasing Organization (October 14, 2020), giving the OptoWire access to more than 50 PCI (percutaneous coronary intervention) centers.

opsens.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-06-17
Description

Strategic partnership (June 17, 2019) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. Opsens Solutions also received funding support (June 16, 2021) to jointly develop an optical-based fuel monitoring system for aerospace applications including civil aircraft.

Strategic tierMinorTypeOthersAnnounced on2019-02-08
Description

Opsens successfully deployed a pressure and temperature system on PTRC's Aquistore Project in Saskatchewan, Canada (February 20, 2013), supporting CO2 storage and monitoring research.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-11-27
Description

Long-standing Japanese distribution partner that converted a US$2 million debenture (November 27, 2017). Zeon Medical is a player in interventional cardiology with a well-organized distribution network; secured Shonin approval for Opsens' FFR products and placed $1.2M of FFR orders (November 30, 2015).

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-08-28
Description

Partnership agreement (August 28, 2015) between Opsens Solutions Inc. and Precise DHS for installation and commissioning of Opsens' OPP-W fiber optic sensors and other products dedicated to heavy oil producers in Western Canada. Reiterated in subsequent OPSENS ANNOUNCES PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES IN THE ENERGY SECTOR (September 22, 2016).

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2011-09-06
Description

Opsens and Lios signed an agreement (September 6, 2011). Specific commercial terms were not disclosed in available press releases.

Strategic tierMinorTypeOthersAnnounced on2007-10-17
Description

Opsens announced an order from BAE Systems (October 17, 2007). Earlier (October 16, 2007), Opsens' RadSens System was accepted for RADHAZ applications by the United Kingdom MoD DOSG (Defence Ordnance Safety Group).

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Specialist in distributed fiber optic sensing for oil & gas, geotechnical, and industrial monitoring. Comparable through fiber optic temperature/strain/pressure sensing for downhole and harsh-environment industrial applications.

TypeDirect peer
Description

Structural heart leader and TAVR incumbent (SAPIEN platform). Directly comparable in the transcatheter aortic valve replacement workflow that Opsens' SavvyWire guidewire is designed to serve.

TypeEmerging player
Description

U.S.-based fiber optic sensing and measurement company with comparable industrial and aerospace/defense sensing applications. Comparable through distributed fiber optic sensing technology serving harsh-environment and structural monitoring markets.

TypeOthers
Description

Acquirer of Opsens (closed December 2023) and parent company; now markets Opsens' fiber optic pressure guidewires via its Hospital business unit and Sensor-Guided Technology platform. Included as the parent/strategic acquirer rather than a competitor.

TypeDirect peer
Description

Direct FFR pressure guidewire competitor (ACIST Navvus) and a litigant in IP disputes against Opsens. Closely comparable in product category, customer base (interventional cardiologists), and business model (capital + disposable).

TypeBroad incumbent
Description

Cardiovascular device incumbent with coronary and structural heart franchises (including TAVR competition via CoreValve/Evolut). Comparable as a competitor in TAVR procedures where Opsens' SavvyWire is positioned and in coronary physiology.

TypeRegional player
Description

Industrial fiber optic temperature and gas sensing company that acquired Opsens' transformers business in 2010. Comparable through industrial fiber optic sensing for power, energy, and harsh-environment applications.

TypeBroad incumbent
Description

Cardiovascular device incumbent offering the COMET FFR pressure guidewire and a broad interventional cardiology portfolio. Directly comparable as an FFR competitor and a previous employer of key Opsens commercial leaders.

TypeBroad incumbent
Description

Owns the Volcano franchise (Verrata pressure guidewire, iFR algorithm), a direct FFR/iFR competitor to Opsens' OptoWire. Comparable through pressure-based coronary physiology products sold to interventional cardiologists globally.

TypeBroad incumbent
Description

Global medical device incumbent whose vascular division sells the PressureWire FFR platform (acquired with St. Jude Medical). Directly competes with Opsens in pressure guidewires for coronary artery disease diagnosis and has a vastly larger sales and clinical evidence base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Opsens

Medical Devices - Interventional Cardiology Pressure Guidewiresopsens.com

Opsens firmographics

Firmographics
Name
Opsens
Legal name
Opsens Inc.
Website
https://opsens.com
Company type
Private
Founded year
2003
Operating status
Acquired
Headcount range
51–100 employees
Ownership category
akta.pro rank

Opsens industry classification

Industry
Product category
Medical Devices - Interventional Cardiology Pressure Guidewires
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)
akta.pro primary industry
Pressure & Force Sensors (Pressure/Strain/Load Cells) (HDAHALAB)

Keywords

  • Fiber optic sensors
  • Medical pressure guidewires
  • Interventional cardiology devices
  • Industrial sensing solutions
  • Downhole pressure monitoring

Where Opsens is headquartered

Location

Headquarters

HQ city
Quebec
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

Opsens business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Medical product sales (FFR guidewires, SavvyWire, OptoMonitor): One-time hardware sales of interventional cardiology fiber optic pressure guidewires (OptoWire, OptoWire II, OptoWire III) and SavvyWire, plus associated OptoMonitor signal conditioners, sold to hospitals and cardiology centers globally.
  2. Industrial fiber optic sensor sales (Oil & Gas, Mining, Aerospace, Defense): One-time hardware sales of fiber optic pressure, temperature, strain and deformation sensors (OPP-W, PowerSens, RadSens, OPP-M25) and complete sensing systems for industrial customers including oil & gas producers, mining operators, aerospace integrators, and defense organizations.
  3. Distribution rights / milestone payments: Recognition of deferred distribution rights and milestone payments from partners upon receipt of regulatory approvals (e.g., US$1M from Japanese partner on Shonin approval, US$2M deferred revenue on CE mark), tied to regional distribution agreements.
  4. Software / algorithm licensing (FFR and dPR): Integration licensing of OptoWire's dPR and FFR algorithms within third-party cardiovascular systems (e.g., Cathmedical Cardiovascular's Picasso System in Spain).

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goQuote-based hardware pricing for FFR guidewires (per unit)
OtherPay-as-you-goProject-based industrial system pricing (mining, oil & gas, aerospace)

Go-to-market motion4 records

Distribution channels9 records

Marketing channels7 records

Opsens product offering

Product offering

Core offering

Opsens designs, manufactures, and sells proprietary fiber optic pressure and temperature sensors for two markets: (1) interventional cardiology, where its OptoWire family of nitinol-based optical pressure guidewires, OptoMonitor display units, dPR diagnostic algorithm, and SavvyWire for TAVR procedures enable Fractional Flow Reserve (FFR) measurement and coronary artery disease diagnosis, and (2) industrial applications including Oil & Gas downhole monitoring (OPP-W sensors), power transformer thermal monitoring (PowerSens II), defense radiation sensing (RadSens), and life sciences miniature sensors (OPP-M25).

Product overview

Opsens operates a platform-plus-modules architecture split between two business units: Opsens Medical and Opsens Solutions. Opsens Medical is the core interventional cardiology offering built around the OptoWire family of nitinol-based optical pressure guidewires (OptoWire I, II, III) used for Fractional Flow Reserve (FFR) and diastolic Pressure Ratio (dPR) measurement, paired with the OptoMonitor / OptoMonitor II display units. This medical portfolio was expanded with the SavvyWire, a second-generation fiber optic guidewire for Transcatheter Aortic Valve Replacement (TAVR) procedures that leverages the same proprietary miniature optical pressure sensing technology. Opsens's algorithms (dPR and FFR) are integrated into partner systems such as Cathmedical Cardiovascular's Picasso System, and its fiber optic pressure sensing technology was FDA-approved for use in Abiomed's Impella cardiac pump. Opsens Solutions is the industrial sister-unit providing fiber optic sensing solutions for Oil & Gas (OPP-W pressure and temperature sensors for SAGD wells and reservoir monitoring), power transformers (PowerSens II signal conditioner), defense (RadSens System for RADHAZ applications), and life sciences (OPP-M25 miniature pressure sensor). As of December 2023, Opsens is a wholly-owned subsidiary of Haemonetics Corporation (NYSE: HAE), and the combined medical sensor-guided technology portfolio is now marketed through Haemonetics.

Differentiator

Problem solved

Functional benefit

Brands

  • Opsens Medical: Medical business unit focused on interventional cardiology FFR and TAVR pressure guidewires (OptoWire, OptoMonitor, SavvyWire).
  • Opsens Solutions

Products and services

  • OptoWire Family (OptoWire I, II, III) Nitinol-based optical pressure guidewires for Fractional Flow Reserve (FFR) and diastolic Pressure Ratio (dPR) measurement in interventional cardiology. Available in three generations with progressively improved hydrophilic coating and flexibility for navigation in tortuous and calcified vessels. Immune to adverse effects from blood contact with reliable zero-drift measurements. Sold to hospitals and cardiology centers.
  • OptoMonitor / OptoMonitor II Display and interface hardware unit that pairs with the OptoWire to record, display, and analyze FFR and dPR measurements during coronary interventions. Provides connection reliability, stable connect/re-connect capability without loss of signal stability, and integrates with FFR and dPR algorithms.
  • SavvyWire Second-generation fiber optic pressure guidewire for Transcatheter Aortic Valve Replacement (TAVR) procedures in the structural heart market. A 3-in-1 guidewire combining pressure measurement with valve delivery workflow to optimize TAVR valve positioning. Received FDA clearance September 2022 and Health Canada approval April 2022.
  • dPR (diastolic Pressure Ratio) Algorithm Proprietary diagnostic algorithm for the assessment of coronary stenosis with the heart at rest. Operates with the OptoWire and OptoMonitor system to expand diagnostic capability beyond stress-based FFR. Licensed and integrated into third-party cardiovascular systems (e.g., Cathmedical Cardiovascular's Picasso System in Spain).
  • OPP-W Fiber Optic Pressure and Temperature Sensors High-end fiber optic pressure and temperature sensors for Oil & Gas producers, providing reliable real-time downhole pressure and temperature data for SAGD wells, electrical submersible pumps, CO2-EOR projects, and reservoir monitoring. Used in high-temperature and harsh downhole environments. Sold to oil sands and heavy oil producers primarily in Western Canada.
  • PowerSens II Signal Conditioner Signal conditioner for the power transformer sector, used with fiber optic temperature sensors for direct thermal monitoring of power transformers. Sold to power utilities and transformer manufacturers.
  • RadSens System Fiber optic radiation sensing system for RADHAZ (Radiation Hazards) applications. Sold to defense organizations including BAE Systems and UK Ministry of Defence.
  • OPP-M25 Miniature Pressure Sensor Miniature fiber optic pressure sensor for life sciences and medical device applications where small form factor and high accuracy are required. Used in OEM applications and laboratory instrumentation.

Quantifiable outcome

  • 100,000 OptoWire cases performed cumulatively by May 2020 (up from 50,000 patients in Nov 2018 and 1,000th procedure in Oct 2015)
  • +4 more outcomes

Companies that use Opsens

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Opsens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Opsens partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered flagship, core and minor.

  • Haemonetics CorporationflagshipStrategic or Co-development Partner · 12 December 2023Haemonetics Corporation (NYSE: HAE) completed acquisition of OpSens on December 12, 2023, acquiring all outstanding shares of OpSens. OpSens' common shares were delisted from the Toronto Stock Exchange and withdrawn from the OTCQX. Opsens is now part of Haemonetics' Hospital business unit and OpSens Medical products (OptoWire, SavvyWire) are marketed via Haemonetics' Sensor-Guided Technology platform. OpSens shares now host its investor relations on Haemonetics' GCS-Web platform.
  • Premier (Group Purchasing Organization)coreChannel Partner/ Reseller/ Distributor · 14 March 2023Interventional Specialty Diagnostics Agreement with Premier for SavvyWire (March 14, 2023); prior agreement for OptoWire III (July 11, 2022). Premier GPO contracts provide Opsens' medical devices access to Premier's network of U.S. hospitals.
  • AbiomedflagshipOEM/ Whitelabel/ Licensing Partner · 1 February 2022Opsens' fiber optic sensing technology integrated into Abiomed's Impella Cardiac Pump (FDA approval announced April 2018). A 4-year supply agreement extension to 2028 was announced February 1, 2022, deepening Opsens' presence within Abiomed's interventional cardiology platform.
  • VizientcoreChannel Partner/ Reseller/ Distributor · 7 April 2021Innovative Technology Contract awarded by Vizient for OptoWire III (April 7, 2021), expanding access to Vizient's U.S. hospital member base.
  • ITER (International Thermonuclear Experimental Reactor)minorOthers · 8 February 2021Opsens Solutions fiber optic sensing technology selected for the ITER project (February 8, 2021), providing fiber optic sensing for this international nuclear fusion research project.
  • Major U.S. Group Purchasing OrganizationcoreChannel Partner/ Reseller/ Distributor · 14 October 2020Opsens was awarded a contract by a major U.S. Group Purchasing Organization (October 14, 2020), giving the OptoWire access to more than 50 PCI (percutaneous coronary intervention) centers.
  • TEMAI IngenierosminorStrategic or Co-development Partner · 17 June 2019Strategic partnership (June 17, 2019) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. Opsens Solutions also received funding support (June 16, 2021) to jointly develop an optical-based fuel monitoring system for aerospace applications including civil aircraft.
  • PTRC (Petroleum Technology Research Centre) / AquistoreminorOthers · 8 February 2019Opsens successfully deployed a pressure and temperature system on PTRC's Aquistore Project in Saskatchewan, Canada (February 20, 2013), supporting CO2 storage and monitoring research.
  • Zeon Medical (Japanese partner)coreChannel Partner/ Reseller/ Distributor · 27 November 2017Long-standing Japanese distribution partner that converted a US$2 million debenture (November 27, 2017). Zeon Medical is a player in interventional cardiology with a well-organized distribution network; secured Shonin approval for Opsens' FFR products and placed $1.2M of FFR orders (November 30, 2015).
  • Precise Downhole Services Ltd. (Precise DHS)coreChannel Partner/ Reseller/ Distributor · 28 August 2015Partnership agreement (August 28, 2015) between Opsens Solutions Inc. and Precise DHS for installation and commissioning of Opsens' OPP-W fiber optic sensors and other products dedicated to heavy oil producers in Western Canada. Reiterated in subsequent OPSENS ANNOUNCES PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES IN THE ENERGY SECTOR (September 22, 2016).
  • LiosminorStrategic or Co-development Partner · 6 September 2011Opsens and Lios signed an agreement (September 6, 2011). Specific commercial terms were not disclosed in available press releases.
  • BAE SystemsminorOthers · 17 October 2007Opsens announced an order from BAE Systems (October 17, 2007). Earlier (October 16, 2007), Opsens' RadSens System was accepted for RADHAZ applications by the United Kingdom MoD DOSG (Defence Ordnance Safety Group).

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Opsens competitors and assessment

Company assessment

Emerging players

  • Silixa: Specialist in distributed fiber optic sensing for oil & gas, geotechnical, and industrial monitoring. Comparable through fiber optic temperature/strain/pressure sensing for downhole and harsh-environment industrial applications.
  • Luna Innovations: U.S.-based fiber optic sensing and measurement company with comparable industrial and aerospace/defense sensing applications. Comparable through distributed fiber optic sensing technology serving harsh-environment and structural monitoring markets.

Direct peers

  • Edwards Lifesciences: Structural heart leader and TAVR incumbent (SAPIEN platform). Directly comparable in the transcatheter aortic valve replacement workflow that Opsens' SavvyWire guidewire is designed to serve.
  • ACIST Medical Systems: Direct FFR pressure guidewire competitor (ACIST Navvus) and a litigant in IP disputes against Opsens. Closely comparable in product category, customer base (interventional cardiologists), and business model (capital + disposable).

Others

  • Haemonetics Corporation: Acquirer of Opsens (closed December 2023) and parent company; now markets Opsens' fiber optic pressure guidewires via its Hospital business unit and Sensor-Guided Technology platform. Included as the parent/strategic acquirer rather than a competitor.

Broad incumbents

  • Medtronic: Cardiovascular device incumbent with coronary and structural heart franchises (including TAVR competition via CoreValve/Evolut). Comparable as a competitor in TAVR procedures where Opsens' SavvyWire is positioned and in coronary physiology.
  • Boston Scientific: Cardiovascular device incumbent offering the COMET FFR pressure guidewire and a broad interventional cardiology portfolio. Directly comparable as an FFR competitor and a previous employer of key Opsens commercial leaders.
  • Philips (Volcano): Owns the Volcano franchise (Verrata pressure guidewire, iFR algorithm), a direct FFR/iFR competitor to Opsens' OptoWire. Comparable through pressure-based coronary physiology products sold to interventional cardiologists globally.
  • Abbott: Global medical device incumbent whose vascular division sells the PressureWire FFR platform (acquired with St. Jude Medical). Directly competes with Opsens in pressure guidewires for coronary artery disease diagnosis and has a vastly larger sales and clinical evidence base.

Regional players

  • LumaSense Technologies: Industrial fiber optic temperature and gas sensing company that acquired Opsens' transformers business in 2010. Comparable through industrial fiber optic sensing for power, energy, and harsh-environment applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Opsens social profiles

Digital presence

Opsens compliance and trust

Trust signal

Compliance5 records

Opsens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Opsens leadership team

Management profile

Number of profiles

Profiles10 records

Opsens subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Opsens funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Opsens M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Opsens

What does Opsens do?

Opsens designs, manufactures, and sells proprietary fiber optic pressure and temperature sensors for two markets: (1) interventional cardiology, where its OptoWire family of nitinol-based optical pressure guidewires, OptoMonitor display units, dPR diagnostic algorithm, and SavvyWire for TAVR procedures enable Fractional Flow Reserve (FFR) measurement and coronary artery disease diagnosis, and (2) industrial applications including Oil & Gas downhole monitoring (OPP-W sensors), power transformer thermal monitoring (PowerSens II), defense radiation sensing (RadSens), and life sciences miniature sensors (OPP-M25).

Is Opsens a public or private company?

Opsens is a private company. It is classified as corporate owned and is currently acquired.

When was Opsens founded?

Opsens was founded in 2003. It employs 51 to 100 people.

Where is Opsens based?

Opsens is headquartered in Quebec, Canada, in the North America region.

How does Opsens make money?

Four revenue lines are on record. Medical product sales (FFR guidewires, SavvyWire, OptoMonitor) is the primary driver. The others are industrial fiber optic sensor sales (Oil & Gas, Mining, Aerospace, Defense), distribution rights / milestone payments and software / algorithm licensing (FFR and dPR).

Who are Opsens's main competitors?

Emerging players on record are Silixa and Luna Innovations. Direct peers are Edwards Lifesciences and ACIST Medical Systems. Haemonetics Corporation is listed as an others. Broad incumbents are Medtronic, Boston Scientific, Philips (Volcano) and Abbott. LumaSense Technologies is listed as a regional player.

Does Opsens have an API?

No public API is recorded for Opsens.

What industry is Opsens in?

Opsens's product category is Medical Devices - Interventional Cardiology Pressure Guidewires. Its primary akta.pro industry code is HDAHALAB, Pressure & Force Sensors (Pressure/Strain/Load Cells). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ticker ReportOpsens (OTCMKTS:OPSSF) Stock Breaks Below 200-Day Moving Average – Should You Sell?Opsens Inc. shares fell below its 200-day moving average of $2.14, trading at $2.1389 on Thursday. The company, a Canadian medical technology firm, develops fiber-optic sensing devices for interventional cardiology and structural heart procedures, including the OptoWire and SavvyWire.Defense WorldOpsens (OTCMKTS:OPSSF) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next?Opsens Inc.'s stock price crossed below its 200-day moving average during trading, with the stock trading at $2.1389 and a volume of 36,000 shares changing hands.NewswireHAEMONETICS COMPLETES ACQUISITION OF OPSENSHaemonetics Corporation has completed the acquisition of all outstanding shares of OpSens Inc. for $2.90 in cash per share, resulting in OpSens being delisted from the Toronto Stock Exchange and OTCQX. The transaction, executed via a statutory plan of arrangement under Québec law, marks the end of OpSens' status as an independent reporting issuer under Canadian securities laws.DOTmedHaemonetics Corporation announces definitive agreement to acquire OpSens, Inc.Haemonetics Corporation has entered into a definitive agreement to acquire OpSens, Inc. in an all-cash transaction valued at approximately USD $253 million. The acquisition aims to expand Haemonetics' leadership in interventional cardiology by integrating OpSens' proprietary optical sensor technology for TAVR and PCI procedures.OpsensOpSens signs definitive agreement for its acquisition by HaemoneticsHaemonetics Corporation has signed a definitive agreement to acquire OpSens Inc. for approximately $345 million, offering $2.90 per share in cash. The transaction, which includes a significant premium over OpSens' recent market price, is expected to close by the end of January 2024 pending regulatory and shareholder approvals.The Globe and MailOPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICSHaemonetics Corporation has signed a definitive agreement to acquire OpSens Inc., a medical device company based in Québec City. The transaction involves Haemonetics and its wholly-owned subsidiary, 9500-7704 Québec Inc., acquiring all outstanding shares of OpSens for an undisclosed amount in Canadian dollars.OpsensOpSens Announces $10 Million Bought Deal OfferingOpSens Inc. announced a $10 million bought deal offering of 5,263,158 common shares at $1.90 per share, with an additional over-allotment option for up to $1.5 million. The company intends to use the net proceeds for working capital and general corporate purposes to support its growth strategy for products like SavvyWire and OptoWire. The offering is expected to close around December 22, 2022, subject to regulatory approvals.NewswireOPSENS INC. ANNOUNCES $10 MILLION BOUGHT DEAL OFFERINGOpSens Inc. announced a $10 million bought deal offering of common shares at $1.90 per share, with an additional option for up to $1.5 million in proceeds if fully exercised. The company intends to use the net proceeds for working capital and general corporate purposes to support its growth strategy, including the commercialization of its SavvyWire product in the U.S., Canada, and New Zealand.PR NewswireOpsens to Webcast, Live, at Virtualinvestorconferences.com, May 11 at 1:30 pm ETOpsens Inc. announced that its President and CEO Louis Laflamme will present at VirtualInvestorConferences.com on May 11, 2017 at 1:30 pm ET. The virtual event will allow investors to ask questions in real-time, with an on-demand archive available for 90 days after the conference. The company aims to become a key player in the guidewire FFR market with its OptoWire product, targeting a market expected to reach US$1 billion in the medium-term.PR NewswireGlobal Pressure Guidewire Market to Reach US$ 1 Billion Benchmark by End of 2024 - PMR ForecastPersistence Market Research released a market study projecting global pressure guidewire revenues to grow from US$ 538.02 million in 2017 to US$ 1,084.6 million by 2024, representing a compound annual growth rate exceeding 10%. The report identifies North America as the dominant regional market with over 30% revenue share in 2017, while Asia-Pacific is forecast to register the fastest growth at 11.5% CAGR through 2024. Key market players including Koninklijke Philips N.V., Abbott Laboratories, Opsens, Inc., and Boston Scientific Corporation are expected to account for nearly two-thirds of global pressure guidewire revenues.